| Literature DB >> 33815527 |
Agata Siedlecka1, Mirela J Wolf-Baca1, Katarzyna Piekarska1.
Abstract
Although antibiotic-resistant bacteria (ARB) have been isolated from tap water worldwide, the knowledge of their resistance patterns is still scarce. Both horizontal and vertical gene transfer has been suggested to contribute to the resistance spread among tap water bacteria. In this study, ARB were isolated from finished water collected at two independent water treatment plants (WTPs) and tap water collected at several point-of-use taps during summer and winter sampling campaigns. A total of 24 strains were identified to genus or species level and subjected to antibiotic and disinfectant susceptibility testing. The investigated tap water ARB belonged to phyla Proteobacteria, Bacteroidetes, Actinobacteria, and Firmicutes. The majority of the isolates proved multidrug resistant and resistant to chemical disinfectant. Neither seasonal nor WTP-dependent variabilities in antibiotic or disinfectant resistance were found. Antibiotics most effective against the investigated isolates included imipenem, tetracyclines, erythromycin, and least effective - aztreonam, cefotaxime, amoxicillin, and ceftazidime. The most resistant strains originate from Afipia sp. and Methylobacterium sp. Comparing resistance patterns of isolated tap water ARB with literature reports concerning the same genera or species confirms intra-genus or even intra-specific variabilities of environmental bacteria. Neither species-specific nor acquired resistance can be excluded.Entities:
Keywords: MIC testing; antibiograms; drinking water bacteria; environmental strains; susceptibility testing
Year: 2021 PMID: 33815527 PMCID: PMC8008766 DOI: 10.33073/pjm-2021-004
Source DB: PubMed Journal: Pol J Microbiol ISSN: 1733-1331
R2A media supplementation for the cultivation of antibiotic-resistant bacteria (ARB) (Siedlecka et al. 2020a; 2020b).
| Antibiotic (abbreviation, final concentration) | ARB |
|---|---|
| Amoxicillin (AML, 8 mg/1) | Bacteria resistant to β-lactams |
| Ciprofloxacin (CIP, 2 mg/1) | Bacteria resistant to fluoroquinolones |
| Ceftazidime (CAZ, 8 mg/1) | Bacteria resistant to 3rd generation cephalosporins |
| Tetracycline (TE, 16 mg/1) | Bacteria resistant to tetracyclines |
Results of molecular identification of strains, % identity of sequence with the reference sequence in the BLAST database, accession No. of the reference sequence.
| Strain No. | Origin | Identification | % Identity | Accession |
|---|---|---|---|---|
| 1 | MD4VII(AML) | 91.28% | MK095762.1 | |
| 2 | MD4VII(CIP) | 100.00% | KM114964.1 | |
| 3 | NGIVIII(CAZ) | 99.55% | LN613126.1 | |
| 4 | NG1VIII(AML) | 99.84% | CP048751.1 | |
| 5 | NG2VIII(CIP) | 99.23% | KY078833.1 | |
| 6 | NG4VIII(CIP) | 99.69% | HM191725.1 | |
| 7 | NG4VIII(AML) | 99.77% | HM191725.1 | |
| 8 | MD2VIII(CIP) | 98.78% | MK271730.1 | |
| 9 | MD4VIII(CIP) | 99.70% | MT542332.1 | |
| 10 | MD4VIII(TE) | 99.54% | MK402948.2 | |
| 11 | MD4VIII(CIP) | 99.69% | MF101018.1 | |
| 12 | NG1I(AML) | 99.69% | CP048751.1 | |
| 13 | NG1I(CAZ) | 99.84% | CP048751.1 | |
| 14 | NG2I(CAZ) | 99.85% | MT355847.1 | |
| 15 | NG2I(CAZ) | 98.92% | MK696981.3 | |
| 16 | NG3I(AML) | 99.39% | KT826375.1 | |
| 17 | NG4I(AML) | 100% | EF660750.1 | |
| 18 | NG4I(CAZ) | 99.32% | JQ977667.1 | |
| 19 | MD1I(CAZ) | 95.24% | MG651160.1 | |
| 20 | MD3I(AML) | 94.86% | KT826375.1 | |
| 21 | MD4I(CIP) | 97.92% | KM252977.1 | |
| 22 | NG1II(CIP) | 99.92% | CP045456.1 | |
| 23 | NG3II(CAZ) | 100% | LN613126.1 | |
| 24 | MD3II(CAZ) | 91.84% | HM327817.1 |
– sample collection site and month, where: NG refers to WTP Na Grobli, MD refers to WTP Mokry Dwór, Arabic numerals refer to consecutive sampling points (1 – finished water at each WTP, 2, 3, 4 – consecutive sampling points in the distribution system within each WTP supply area), Roman numerals refer to the month of sample collection, abbreviations in brackets refer to R2A media supplementation – the plate from which the strain was initially isolated. Strains are ordered by the month of collection.
Results of antibiotic and disinfectant susceptibility testing.
| Strain No. | Aminopenicillins | Monobactams | Carbapenems | Fluoroquinolones | Cephalosporins | Tetracyclines | Glyco-peptides | Aminoglycosides | Sulfonamides | Macrolides | Others | Total | Disinfectants | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AM | ATM | ETP | IMP | MEM | OFX | CTX | FEP | DO | T | VA | CN | S | SXT | E | RA | C | PB | Cl2 | D | ||
| 1 | • | • | • | • | • | 5 | • | • | |||||||||||||
| 2 | • | • | 2 | • | • | ||||||||||||||||
| 3 | • | 1 | • | • | |||||||||||||||||
| 4 | • | • | • | • | • | • | • | 7 | • | • | |||||||||||
| 5 | • | • | • | • | • | • | • | • | 8 | • | • | ||||||||||
| 6 | • | • | • | • | • | • | • | • | • | 9 | • | • | |||||||||
| 7 | • | • | • | • | • | • | • | • | 8 | • | • | ||||||||||
| 8 | • | • | • | • | • | • | 6 | • | • | ||||||||||||
| 9 | • | • | • | • | • | • | • | • | • | 9 | • | • | |||||||||
| 10 | • | • | • | • | • | • | • | • | • | • | • | • | 12 | • | • | ||||||
| 11 | • | 1 | • | ||||||||||||||||||
| 12 | • | • | • | • | • | 5 | • | • | |||||||||||||
| 13 | • | • | • | • | • | • | 6 | • | • | ||||||||||||
| 14 | • | • | • | • | 4 | • | • | ||||||||||||||
| 15 | • | • | 2 | ||||||||||||||||||
| 16 | • | • | • | • | 4 | • | • | ||||||||||||||
| 17 | • | • | • | • | • | • | • | 7 | • | • | |||||||||||
| 18 | 0 | ||||||||||||||||||||
| 19 | • | 1 | • | ||||||||||||||||||
| 20 | • | • | • | • | 4 | • | • | ||||||||||||||
| 21 | |||||||||||||||||||||
| 22 | • | • | • | • | 4 | • | • | ||||||||||||||
| 23 | 0 | • | |||||||||||||||||||
| 24 | • | • | • | • | • | • | • | • | • | • | • | • | 12 | • | |||||||
| Total | 11 | 16 | 6 | 0 | 3 | 11 | 16 | 7 | 1 | 2 | 5 | 7 | 3 | 8 | 1 | 9 | 5 | 6 | |||
• – resistant; — not included in the testing
Cl2 – 14.5% sodium hypochlorite; D – commercial disinfectant
The abbreviations of antibiotics are explained in the Materials and Methods section.
Antibiotic groups are in accordance with ATC Classification System (WHO ATC Index).
Results of MIC testing (gg/ml).
| Strain No. | AML | AMC | CIP | CAZ | CZA | TE |
|---|---|---|---|---|---|---|
| 1 | > 256 | 0.75 | – | 32 | 0.75 | – |
| 2 | 10 | < 0.016 | – | 32 | 32 | – |
| 3 | 10 | 0.25 | – | > 256 | > 256 | – |
| 4 | > 256 | 2 | 4 | > 256 | > 256 | – |
| 5 | 16 | 0.5 | > 32 | > 256 | < 0.016 | – |
| 6 | 96 | 1.5 | 12 | 10 | < 0.016 | – |
| 7 | 24 | 8 | 4 | – | – | – |
| 8 | 10 | 0.047 | > 32 | > 256 | > 256 | – |
| 9 | – | – | 6 | > 256 | > 256 | 24 |
| 10 | 64 | 4 | – | > 256 | > 256 | > 256 |
| 11 | – | – | – | 10 | 0.38 | – |
| 12 | > 256 | 2 | – | 96 | 64 | – |
| 13 | > 256 | 1.5 | – | > 256 | > 256 | – |
| 14 | 10 | 24 | – | > 256 | > 256 | – |
| 15 | 10 | 0.5 | – | > 256 | 64 | – |
| 16 | > 256 | 1.5 | – | 10 | 4 | – |
| 17 | 32 | 24 | > 32 | > 256 | > 256 | – |
| 18 | 10 | 0.5 | – | > 256 | > 256 | – |
| 19 | – | – | – | > 256 | > 256 | – |
| 20 | > 256 | 0.5 | – | 10 | 1 | – |
| 21 | – | – | – | – | – | – |
| 22 | 10 | 0.125 | 4 | > 256 | > 256 | – |
| 23 | 12 | 1 | – | > 256 | > 256 | – |
| 24 | > 256 | 24 | > 32 | > 256 | > 256 | – |
– – not included in the testing (strain susceptible to the antibiotic)
The abbreviations of antibiotics are explained in the Materials and Methods section.